Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases-Reference-Cited by-同舟云学术

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

Published:2013-05 Issue:5 Volume:11 Page:558-564.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ghabril Marwan,Bonkovsky Herbert L.,Kum Clarissa,Davern Tim,Hayashi Paul H.,Kleiner David E.,Serrano Jose,Rochon Jim,Fontana Robert J.,Bonacini Maurizio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Clinically significant liver injury in patients treated with natalizumab;Bezabeh;Aliment Pharmacol Ther,2010

2. Hepatotoxicity of immunomodulator agents and the transplant situation;Davern,2007

3. Use of tumor necrosis factor-α inhibitors in patients with chronic hepatitis B infection;Carroll;Semin Arthritis Rheum,2008

4. Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab;García Aparicio;Clin Rheumatol,2007

5. Infliximab-induced hepatitis: absence of cross-toxicity with etanercept;Thiéfin;Joint Bone Spine,2008

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of abnormal liver blood tests in patients with inflammatory bowel disease;Frontline Gastroenterology;2024-09-02

2. Certolizumab-Induced Liver Injury in Ankylosing Spondylitis: A Case Report and Causality Assessment;Cureus;2024-08-10

3. Iron regulatory protein 2 contributes to antimicrobial immunity by preserving lysosomal function in macrophages;Proceedings of the National Academy of Sciences;2024-07-24

4. Inflammatory Bowel Disease Therapies and Acute Liver Injury;Toxics;2024-06-08

5. Hepatotoxicity in inflammatory bowel disease: Immunomodulators, biologics, and beyond;Clinical Liver Disease;2024-01